Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | HTR3E | A5X5Y0 | 3/20 | 0.45 |
| ▸ | HTR3B | O95264 | 3/20 | 0.45 |
| ▸ | HTR3A | P46098 | 3/20 | 0.45 |
| ▸ | HTR3D | Q70Z44 | 3/20 | 0.45 |
| ▸ | HTR3C | Q8WXA8 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | SLC22A2 | O15244 | 2/20 | 0.45 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.45 |
| ▸ | SLC22A3 | O75751 | 2/20 | 0.45 |
| ▸ | PLAU | P00749 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4401206 | 0.90 | ESR2 (0.55) | CES2CES1ALDH1A1LMNAESR2 | |
| SCHEMBL23481580 | 0.82 | ESR2 (0.69) | CES2CES1ALDH1A1LMNAESR2 | |
| SCHEMBL31285549 | 0.82 | LMNA (0.49) | CES2CES1ALDH1A1LMNAESR2 | |
| SCHEMBL15073407 | 0.82 | LMNA (0.49) | CES2CES1ALDH1A1LMNAESR2 | |
| SCHEMBL16373407 | 0.80 | HPGD (0.56) | ALDH1A1MAPTHTR3EHTR3BHTR3A | |
| SCHEMBL11421050 | 0.80 | CYP2D6 (0.53) | CES2CES1ALDH1A1LMNAESR2 | |
| SCHEMBL11421052 | 0.80 | CYP2D6 (0.53) | CES2CES1ALDH1A1LMNAESR2 | |
| SCHEMBL22594341 | 0.80 | CYP2D6 (0.63) | CES2CES1ALDH1A1LMNAESR2 | |
| SCHEMBL16382908 | 0.80 | CYP2D6 (0.53) | CES2CES1ALDH1A1LMNAESR2 | |
| SCHEMBL16336077 | 0.74 | LMNA (0.44) | CES2CES1ALDH1A1LMNAESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9650310-B2 | Method for the methylation of nitrogen-containing organic compounds | RHEINISCHE-WESTFÄLISCHE TECHNISCHE HOCHSCHULE (RWTH) AACHEN (DE) | 2017-05-16 | — | — | US | disclosed |
| US-20160168043-A1 | METHOD FOR THE METHYLATION OF NITROGEN-CONTAINING ORGANIC COMPOUNDS | RHEINISCHE-WESTFÄLISCHE TECHNISCHE HOCHSCHULE (RWTH) AACHEN (DE) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168043-A1 | METHOD FOR THE METHYLATION OF NITROGEN-CONTAINING ORGANIC COMPOUNDS | HNMT, PNMT, GNMT | CES2 1913/4885CES1 4348/4885ALDH1A1 3722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.